+30.4%
GSK vs EVRG
+17.4%
+13.0%
-18.5%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | EVRG | Excess | Alpha |
|---|---|---|---|---|
| 1D | -1.9% | -0.5% | -1.5% | -1.7% |
| 7D | -1.8% | +1.1% | -2.9% | -2.2% |
| 30D | -2.2% | -1.0% | -1.2% | -1.8% |
| 3M | -1.8% | +0.4% | -2.2% | -1.7% |
| 6M | -10.6% | -0.8% | -9.8% | -10.3% |
| YTD | +4.4% | +15.3% | -10.9% | +0.3% |
| 1Y | +30.4% | +17.9% | +12.5% | +15.1% |
| All | +30.4% | +17.4% | +13.0% | +15.1% |
Cumulative growth
Daily Returns
Daily percentage return beside EVRG.
Daily Out/Under-Performance
Portfolio return minus EVRG return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × EVRG return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded EVRG wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling